Cargando…
Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis
SIMPLE SUMMARY: When breast cancer metastasizes to the lung, group 2 innate lymphoid cells (ILC2s) are thought to promote tumor growth via the activation of myeloid-derived suppressor cells (MDSCs). In this study, we aimed to characterize the dynamic interactions of ILC2s and MDSCs during the course...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265472/ https://www.ncbi.nlm.nih.gov/pubmed/35805039 http://dx.doi.org/10.3390/cancers14133267 |
_version_ | 1784743222936862720 |
---|---|
author | Ito, Atsushi Akama, Yuichi Satoh-Takayama, Naoko Saito, Kanako Kato, Takuma Kawamoto, Eiji Gaowa, Arong Park, Eun Jeong Takao, Motoshi Shimaoka, Motomu |
author_facet | Ito, Atsushi Akama, Yuichi Satoh-Takayama, Naoko Saito, Kanako Kato, Takuma Kawamoto, Eiji Gaowa, Arong Park, Eun Jeong Takao, Motoshi Shimaoka, Motomu |
author_sort | Ito, Atsushi |
collection | PubMed |
description | SIMPLE SUMMARY: When breast cancer metastasizes to the lung, group 2 innate lymphoid cells (ILC2s) are thought to promote tumor growth via the activation of myeloid-derived suppressor cells (MDSCs). In this study, we aimed to characterize the dynamic interactions of ILC2s and MDSCs during the course of cancer progression from the micrometastatic to the macrometastatic stages. We found that ILC2s were activated in both the micro- and macrometastatic regions, suggesting sustained activation throughout the metastatic cascades. In addition, our findings indicate that ILC2s may induce the immunosuppressive functions of MDSCs during the later stages of metastasis. Concomitantly, ILC2 may instigate extracellular matrix remodeling by polymorphonuclear (PMN)-MDSC activation during the early stages of metastasis. These metastatic-stage-specific changes may contribute to metastatic tumor growth in the microenvironment of breast cancer lung metastasis. ABSTRACT: Breast cancer is the most common cancer in women worldwide, and lung metastasis is one of the most frequent distant metastases. When breast cancer metastasizes to the lung, group 2 innate lymphoid cells (ILC2s) are thought to promote tumor growth via the activation of myeloid-derived suppressor cells (MDSCs), which are known to negatively regulate anticancer immune responses. However, it remains to be elucidated exactly how this ILC2–MDSC interaction is involved in tumor growth during metastases formation. Using a 4T1/LM4 breast cancer mouse model, we found that ILC2s were activated in both the micro- and macrometastatic regions, suggesting sustained activation throughout the metastatic cascades via IL-33/ST2 signaling. Consistent with IL-13 secretion from activated ILC2s, the frequencies of polymorphonuclear (PMN)- and monocytic (M)-MDSCs were also significantly elevated during the progression from micro- to macrometastatic cancer. However, the effects of ILC2-induced MDSC functionality on the microenvironment differed in a metastatic-stage-specific manner. Our findings indicate that ILC2s may induce the immunosuppressive functions of MDSCs during the later stages of metastasis. Concomitantly, ILC2 may instigate extracellular matrix remodeling by PMN-MDSC activation during the early stages of metastasis. These metastatic-stage-specific changes may contribute to metastatic tumor growth in the microenvironment of breast cancer lung metastasis. |
format | Online Article Text |
id | pubmed-9265472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92654722022-07-09 Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis Ito, Atsushi Akama, Yuichi Satoh-Takayama, Naoko Saito, Kanako Kato, Takuma Kawamoto, Eiji Gaowa, Arong Park, Eun Jeong Takao, Motoshi Shimaoka, Motomu Cancers (Basel) Article SIMPLE SUMMARY: When breast cancer metastasizes to the lung, group 2 innate lymphoid cells (ILC2s) are thought to promote tumor growth via the activation of myeloid-derived suppressor cells (MDSCs). In this study, we aimed to characterize the dynamic interactions of ILC2s and MDSCs during the course of cancer progression from the micrometastatic to the macrometastatic stages. We found that ILC2s were activated in both the micro- and macrometastatic regions, suggesting sustained activation throughout the metastatic cascades. In addition, our findings indicate that ILC2s may induce the immunosuppressive functions of MDSCs during the later stages of metastasis. Concomitantly, ILC2 may instigate extracellular matrix remodeling by polymorphonuclear (PMN)-MDSC activation during the early stages of metastasis. These metastatic-stage-specific changes may contribute to metastatic tumor growth in the microenvironment of breast cancer lung metastasis. ABSTRACT: Breast cancer is the most common cancer in women worldwide, and lung metastasis is one of the most frequent distant metastases. When breast cancer metastasizes to the lung, group 2 innate lymphoid cells (ILC2s) are thought to promote tumor growth via the activation of myeloid-derived suppressor cells (MDSCs), which are known to negatively regulate anticancer immune responses. However, it remains to be elucidated exactly how this ILC2–MDSC interaction is involved in tumor growth during metastases formation. Using a 4T1/LM4 breast cancer mouse model, we found that ILC2s were activated in both the micro- and macrometastatic regions, suggesting sustained activation throughout the metastatic cascades via IL-33/ST2 signaling. Consistent with IL-13 secretion from activated ILC2s, the frequencies of polymorphonuclear (PMN)- and monocytic (M)-MDSCs were also significantly elevated during the progression from micro- to macrometastatic cancer. However, the effects of ILC2-induced MDSC functionality on the microenvironment differed in a metastatic-stage-specific manner. Our findings indicate that ILC2s may induce the immunosuppressive functions of MDSCs during the later stages of metastasis. Concomitantly, ILC2 may instigate extracellular matrix remodeling by PMN-MDSC activation during the early stages of metastasis. These metastatic-stage-specific changes may contribute to metastatic tumor growth in the microenvironment of breast cancer lung metastasis. MDPI 2022-07-04 /pmc/articles/PMC9265472/ /pubmed/35805039 http://dx.doi.org/10.3390/cancers14133267 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ito, Atsushi Akama, Yuichi Satoh-Takayama, Naoko Saito, Kanako Kato, Takuma Kawamoto, Eiji Gaowa, Arong Park, Eun Jeong Takao, Motoshi Shimaoka, Motomu Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis |
title | Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis |
title_full | Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis |
title_fullStr | Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis |
title_full_unstemmed | Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis |
title_short | Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis |
title_sort | possible metastatic stage-dependent ilc2 activation induces differential functions of mdscs through il-13/il-13rα1 signaling during the progression of breast cancer lung metastasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265472/ https://www.ncbi.nlm.nih.gov/pubmed/35805039 http://dx.doi.org/10.3390/cancers14133267 |
work_keys_str_mv | AT itoatsushi possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT akamayuichi possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT satohtakayamanaoko possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT saitokanako possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT katotakuma possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT kawamotoeiji possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT gaowaarong possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT parkeunjeong possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT takaomotoshi possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis AT shimaokamotomu possiblemetastaticstagedependentilc2activationinducesdifferentialfunctionsofmdscsthroughil13il13ra1signalingduringtheprogressionofbreastcancerlungmetastasis |